Jiangsu Bioperfectus Stock Hits Day Low at CNY 31.50 Amid Price Pressure

Jiangsu Bioperfectus Technologies Co., Ltd. experienced significant volatility on July 17, 2026, with the stock declining by 14.19% and reaching an intraday low of CNY 31.50. This performance starkly contrasts with the China Shanghai Composite, which fell by 3.05% on the same day. Over the past week, Jiangsu Bioperfectus has seen a decrease of 2.45%, while its one-month performance reflects a decline of 7.61%. Year-to-date, the stock has dropped by 31.94%, indicating a challenging market environment for the company. In the last year, the stock has faced a notable decline of 14.83%, diverging from the positive trajectory of the China Shanghai Composite, which has gained 7.03%. Financial metrics reveal that Jiangsu Bioperfectus has struggled with long-term growth, as evidenced by a net sales decline of 22.40% annually over the past five years. The company's operating profit has also been significantly negative, reflecting broader challenges within the pharmaceuticals and biotechnology sector. With a market capitalization of CNY 3,935 million, the company continues to navigate a complex financial landscape.